PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 11, 2015Expert Opinion on Drug Safety

Immunogenicity of infliximab and adalimumab: what is its role in hypersensitivity and modulation of therapeutic efficacy and safety?

View Full Paper
Ask AI
Bookmark
Share

Authors

GMGiuseppe MurdacaFSFrancesca SpanòMCMiriam Contatore

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Murdaca et al. (2015) studied this question.

synapsesocial.com/papers/6a19f9a33f3ec013f0df51ebhttps://doi.org/10.1517/14740338.2016.1112375
View Full Paper
Ask AI
Bookmark
Share